Townsend S - Search Results

1

Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency.

Townsend S, Newsome P, Turner AM. Townsend S, et al. Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):745-747. doi: 10.1080/17474124.2018.1477589. Epub 2018 May 28. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29768056 Review. No abstract available.

2

The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016.

Townsend SA, Newsome PN. Townsend SA, et al. Dig Dis. 2017;35(4):371-376. doi: 10.1159/000456589. Epub 2017 May 3. Dig Dis. 2017. PMID: 28468015 Review.

3

Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease.

Townsend SA, Edgar RG, Ellis PR, Kantas D, Newsome PN, Turner AM. Townsend SA, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):877-885. doi: 10.1111/apt.14537. Epub 2018 Feb 15. Aliment Pharmacol Ther. 2018. PMID: 29446109

4

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, Corbett C, Townsend S, Thomas J, Guo K, Hull D, Beard HA, Thompson J, Atkinson A, Bienek C, McGowan N, Guha N, Campbell J, Hollyman D, Stocken D, Yap C, Forbes SJ. Newsome PN, et al. Among authors: townsend s. Lancet Gastroenterol Hepatol. 2018 Jan;3(1):25-36. doi: 10.1016/S2468-1253(17)30326-6. Epub 2017 Nov 7. Lancet Gastroenterol Hepatol. 2018. PMID: 29127060 Free PMC article. Clinical Trial.

5

Non-alcoholic fatty liver disease in 2016.

Townsend SA, Newsome PN. Townsend SA, et al. Br Med Bull. 2016 Sep;119(1):143-56. doi: 10.1093/bmb/ldw031. Epub 2016 Aug 19. Br Med Bull. 2016. PMID: 27543499 Free PMC article. Review.

6

Review article: new treatments in non-alcoholic fatty liver disease.

Townsend SA, Newsome PN. Townsend SA, et al. Aliment Pharmacol Ther. 2017 Sep;46(5):494-507. doi: 10.1111/apt.14210. Epub 2017 Jul 4. Aliment Pharmacol Ther. 2017. PMID: 28677333 Free article. Review.

7

Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity.

Townsend SA, Newsome PN. Townsend SA, et al. Aliment Pharmacol Ther. 2017 Aug;46(4):459-460. doi: 10.1111/apt.14179. Aliment Pharmacol Ther. 2017. PMID: 28707791 No abstract available.

8

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.

Schilter H, Findlay AD, Perryman L, Yow TT, Moses J, Zahoor A, Turner CI, Deodhar M, Foot JS, Zhou W, Greco A, Joshi A, Rayner B, Townsend S, Buson A, Jarolimek W. Schilter H, et al. Among authors: townsend s. J Cell Mol Med. 2019 Mar;23(3):1759-1770. doi: 10.1111/jcmm.14074. Epub 2018 Dec 9. J Cell Mol Med. 2019. PMID: 30536539 Free PMC article.

9

Is pentoxifylline still an option in severe alcoholic hepatitis?

Townsend SA, Rowe IA, Elsharkawy AM. Townsend SA, et al. Hepatology. 2015 Nov;62(5):1643-4. doi: 10.1002/hep.27782. Epub 2015 May 12. Hepatology. 2015. PMID: 25773475 No abstract available.

10

Rescue from liver transplantation: TIPSS and thrombectomy successfully treat a case of acute Budd-Chiari syndrome complicated by portal vein thrombosis.

Townsend SA, Karkhanis S, Tripathi D, Mueisan P, Zia Z, Elsharkawy AM. Townsend SA, et al. BJR Case Rep. 2016 Jul 27;3(1):20160059. doi: 10.1259/bjrcr.20160059. eCollection 2017. BJR Case Rep. 2016. PMID: 30363345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters